Skip to main content
main-content

Zeitschrift

Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy 2/2010

Ausgabe 2/2010

Inhaltsverzeichnis ( 17 Artikel )

01.02.2010 | Review | Ausgabe 2/2010

Survivin as an immunotherapeutic target for adult and pediatric malignant brain tumors

Rebecca Liu, Duane A. Mitchell

01.02.2010 | Review | Ausgabe 2/2010

Multimer technologies for detection and adoptive transfer of antigen-specific T cells

Rosaely Casalegno-Garduño, Anita Schmitt, Junxia Yao, Xinchao Wang, Xun Xu, Mathias Freund, Michael Schmitt

01.02.2010 | Original Article | Ausgabe 2/2010 Open Access

Loci controlling lymphocyte production of interferon γ after alloantigen stimulation in vitro and their co-localization with genes controlling lymphocyte infiltration of tumors and tumor susceptibility

Marie Lipoldová, Helena Havelková, Jana Badalová, Jarmila Vojtíšková, Lei Quan, Magdaléna Krulová, Yahya Sohrabi, Alphons P. Stassen, Peter Demant

01.02.2010 | Original Article | Ausgabe 2/2010

Systemic dysregulation of CEACAM1 in melanoma patients

Gal Markel, Rona Ortenberg, Rachel Seidman, Sivan Sapoznik, Nira Koren-Morag, Michal J. Besser, Jair Bar, Ronnie Shapira, Adva Kubi, Gil Nardini, Ariel Tessone, Avraham J. Treves, Eyal Winkler, Arie Orenstein, Jacob Schachter

01.02.2010 | Original Article | Ausgabe 2/2010

Antibody to CCDC104 is associated with a paraneoplastic antibody to CDR2 (anti-Yo)

Cecilie Totland, Geir Bredholt, Mette Haugen, Bjørn Ivar Haukanes, Christian A. Vedeler

01.02.2010 | Original Article | Ausgabe 2/2010

Assessment of the pre-clinical immunogenicity of a new VEGF receptor Fc-fusion protein FP3 with ELISA and BIACORE

Hui Wang, Jing Shi, Qin Wang, Hong Li, Kun Cai, Xiaojun Hou, Tao Li, Qi Zhong, Dechao Yu

01.02.2010 | Original Article | Ausgabe 2/2010

Dynamic monitoring the TCR CDR3 spectratypes in patients with metastatic CRC treated with a combination of bevacizumab, irinotecan, fluorouracil, and leucovorin

Wei Luo, Wang-Jun Liao, Li Ma, Yong-Ta Huang, Min Shi, Qian Wen, Xiao-Ning Wang

01.02.2010 | Original Article | Ausgabe 2/2010

A nonfucosylated human antibody to CD19 with potent B-cell depletive activity for therapy of B-cell malignancies

Pina M. Cardarelli, Chetana Rao-Naik, Sharline Chen, Haichun Huang, Amie Pham, Maria-Cristina Moldovan-Loomis, Chin Pan, Ben Preston, David Passmore, Jie Liu, Michelle R. Kuhne, Alison Witte, Diann Blanset, David J. King

01.02.2010 | Original Article | Ausgabe 2/2010

Tumors induce the formation of suppressor endothelial cells in vivo

Jennifer Konopa Mulligan, M. Rita I. Young

01.02.2010 | Original Article | Ausgabe 2/2010

The immunologic aspects in advanced ovarian cancer patients treated with paclitaxel and carboplatin chemotherapy

Xia Wu, Qin-Mei Feng, Ying Wang, Jun Shi, Hai-Liang Ge, Wen Di

01.02.2010 | Original Article | Ausgabe 2/2010

A phase II trial of intraperitoneal interleukin-2 in patients with platinum-resistant or platinum-refractory ovarian cancer

Anda M. Vlad, Raluca A. Budiu, Diana E. Lenzner, Yun Wang, Julia A. Thaller, Kelly Colonello, Peggy A. Crowley-Nowick, Joseph L. Kelley, Fredric V. Price, Robert P. Edwards

01.02.2010 | Original Article | Ausgabe 2/2010 Open Access

Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?

Marna G. Bouwhuis, Andreas Gast, Adina Figl, Alexander M. M. Eggermont, Kari Hemminki, Dirk Schadendorf, Rajiv Kumar

01.02.2010 | Original Article | Ausgabe 2/2010

Autophagy facilitates major histocompatibility complex class I expression induced by IFN-γ in B16 melanoma cells

Bo Li, Zhang Lei, Brain D. Lichty, Dong Li, Gui-Mei Zhang, Zuo-Hua Feng, Yonghong Wan, Bo Huang

01.02.2010 | Original Article | Ausgabe 2/2010

Immune impairment in patients with terminal cancers: influence of cancer treatments and cytomegalovirus infection

I-Hsuan Chen, Yuen-Liang Lai, Chien-Liang Wu, Yi-Fang Chang, Chen-Chung Chu, I-Fang Tsai, Fang-Ju Sun, Yen-Ta Lu

01.02.2010 | Letter to the editor | Ausgabe 2/2010

Impact of Cytomegalovirus infection on immune signatures in cancer patients

Evelyna Derhovanessian

01.02.2010 | Letter to the editor | Ausgabe 2/2010

Response to Dr Derhovanessian “Impact of cytomegalovirus infection on immune signatures in cancer patients”

Yen-Ta Lu, I-Hsuan Chen

01.02.2010 | Erratum | Ausgabe 2/2010

Erratum to: Amyloid precursor-like protein 2 association with HLA class I molecules

Amit Tuli, Mahak Sharma, Xiaojian Wang, Laura C. Simone, Haley L. Capek, Steven Cate, William H. Hildebrand, Naava Naslavsky, Steve Caplan, Joyce C. Solheim

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise